Most people arrive at surrogacy after something else didn’t work. A failed IVF round. Two. Sometimes five. By the time they’re researching gestational carriers, they’ve already absorbed more medical terminology than they ever wanted to know — and they’re exhausted. What often catches them off guard is learning that surrogacy and egg donation aren’t mutually exclusive. For a significant portion of intended parents, the answer isn’t one or the other. It’s both, coordinated inside a single program. Finding the right best surrogacy agency at that stage isn’t just a logistics decision — it’s the difference between a protocol that works and one that falls apart at the handoff. A dedicated surrogacy clinic in Ukraine is one of the few places internationally where both services operate under a unified legal and medical framework, available to foreign nationals without the jurisdictional patchwork that plagues other destinations.
But before any of that — why do the two end up combined in the first place?
The Biology Doesn’t Always Cooperate
Here’s the part that surprises people: surrogacy addresses the uterus. Not the eggs.
If a woman’s ovaries still produce viable eggs but her uterus can’t sustain a pregnancy — due to congenital abnormalities, severe Asherman’s syndrome, repeated implantation failure, or a medical condition that makes carrying dangerous — gestational surrogacy solves the problem. Her eggs, her partner’s sperm, a surrogate’s womb. That’s the straightforward version.
The combined path comes in when the eggs are also off the table. Premature ovarian insufficiency. An AMH so low the stimulation protocol yields two follicles on a good day. Carrier status for a genetic condition the parents won’t pass on. Or — increasingly common — same-sex male couples where there’s simply no egg source in the partnership.
In these situations, a donor provides the oocytes. The surrogate provides the uterus. The intended father — or a sperm donor — provides the sperm. That’s three biological contributors to one embryo, all coordinated to a single transfer window. Getting that timing right is where most programs either earn their fee or quietly fail.
What the Protocol Actually Looks Like
The synchronization problem is real. And it’s underappreciated.
The donor side
An egg donor undergoes controlled ovarian stimulation — injectable gonadotropins, typically for 10 to 14 days, with ultrasound monitoring every two to three days to track follicular growth. When the lead follicles hit roughly 18 millimeters, a trigger shot initiates final maturation. Retrieval happens 35 to 36 hours later under light sedation. A well-responding donor in her mid-twenties might yield 12 to 18 mature oocytes. An older or poor-responding donor, far fewer.
Before any of that, the donor has already cleared infectious disease screening, a full genetic carrier panel, psychological evaluation, and a uterine assessment — not because her uterus matters here, but because the clinic is verifying she understands the process and isn’t being coerced. That screening takes weeks. It starts long before the stimulation cycle does.
The embryology
Retrieved oocytes are fertilized — usually via ICSI, which gives the embryologist direct control over fertilization — and cultured to blastocyst stage over five to six days. Day five is the decision point: which embryos are viable, which get biopsied for preimplantation genetic testing (PGT-A), which get vitrified, which get transferred fresh.
PGT-A screens for chromosomal aneuploidy. A euploid blastocyst transferred to a prepared uterus at an experienced center currently achieves clinical pregnancy rates in the range of 60 to 65 percent per transfer. That’s not a guarantee. But it’s a meaningful number compared to untested embryos, where the rate drops significantly and miscarriage risk climbs.
The surrogate side
While the embryos are developing — or while vitrified embryos sit in storage — the surrogate undergoes endometrial preparation. Estrogen first, to build the lining. Progesterone added roughly five days before the planned transfer, to trigger secretory transformation. Target thickness: 8 to 12 millimeters on ultrasound, with a trilaminar pattern.
If the donor’s retrieval is delayed, the surrogate’s progesterone start gets pushed. If the surrogate’s lining responds slowly, the transfer date moves. These adjustments are routine. The problem is when they require coordination between two separate organizations — a donor agency in one city, a surrogacy program in another, an embryology lab somewhere in the middle. Each handoff is a place where information gets lost or timing gets misread.
Why One Roof Changes the Math
This isn’t an argument for convenience. It’s an argument for failure rate reduction.
When a single clinic manages the donor pool, the embryology lab, and the surrogate program, schedule adjustments happen internally. The reproductive endocrinologist overseeing the donor stimulation is the same one monitoring the surrogate’s lining. When something shifts — and something always shifts — the response doesn’t require a phone call between organizations, a contract review, or a renegotiated timeline.
There’s also the legal layer. In jurisdictions where surrogacy is legal and regulated, having the egg donation contract and the gestational carrier agreement governed under the same national law, drafted by lawyers who work with the same clinic, closes gaps that international multi-provider arrangements leave open. Parentage orders, birth registration, exit documentation for the child — these move faster when everyone is operating from the same legal playbook.
Where ivmed.agency Fits Into This
ivmed.agency is not a matching service that outsources the medical side. The donor program, the surrogacy program, and the embryology lab operate as a single unit. Donors are recruited, screened, and medically managed in-house. Surrogates undergo independent psychological evaluation before entering the program — not as a formality, but because the clinic has seen what happens when that step gets skipped.
For international patients specifically, the program includes coordination of legal documentation, apostille procedures, and exit paperwork for the child — the bureaucratic layer that often blindsides families who assumed the birth was the finish line. It isn’t.
Pricing is fixed per program, not itemized per procedure. After years of unexpected costs in prior treatment cycles, most intended parents find that predictability worth more than a lower headline number that grows.
If the question right now is whether this path makes medical sense for your specific situation, the clinic offers consultations that review your history and give a direct answer — not a sales call.
